ADUS Director Receives 1,172 Restricted Shares – Routine Form 4 Filing
Form 4 filing overview – Addus HomeCare Corp. (ADUS) Director Darin J. Gordon reported the grant of 1,172 restricted common shares on 18-Jun-2025.
Rhea-AI Filing Summary
Form 4 filing overview – Addus HomeCare Corp. (ADUS)
Director Darin J. Gordon reported the grant of 1,172 restricted common shares on 18-Jun-2025. The award was received at $0 cost under a standard non-employee director compensation plan and will vest in full on 18-Jun-2026. Following the grant, Gordon’s direct ownership rises to 12,795 ADUS shares.
No derivative securities were reported, and there were no sales or open-market purchases. The filing represents routine equity compensation intended to align the director’s interests with shareholders and does not signal a change in company fundamentals.
Positive
- Director’s equity stake increases by 1,172 shares, modestly strengthening alignment with shareholder interests.
Negative
- None.
Insights
TL;DR: Routine director grant; neutral impact.
The 1,172-share restricted stock award is typical annual compensation for Addus HomeCare’s outside directors. At today’s market price (~$95 per share), the grant is worth roughly $111k, immaterial to the company’s $1.5 bn market cap. Because the award vests over one year and involves no open-market buying or selling, it does not alter the supply–demand balance or signal insider sentiment. The filing is therefore informational rather than market-moving.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,172 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.
FAQ
What did director Darin J. Gordon report in the Form 4 for ADUS?
Does this Form 4 filing impact Addus HomeCare’s fundamentals?
AI-generated analysis. How Rhea-AI works. Not financial advice.